Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
30.13 +0.57 (+1.93%) 04/02/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 28.00 -2.13 (-7.07%) 19:44 ET
Quote Overview for Wed, Apr 2nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
28.65
Day High
30.87
Open 29.00
Previous Close 29.56 29.56
Volume 808,900 808,900
Avg Vol 920,355 920,355
Stochastic %K 22.22% 22.22%
Weighted Alpha +14.45 +14.45
5-Day Change -0.92 (-2.96%) -0.92 (-2.96%)
52-Week Range 18.61 - 47.32 18.61 - 47.32
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,304,054
  • Shares Outstanding, K 77,945
  • Annual Sales, $ 445,760 K
  • Annual Income, $ 24,140 K
  • EBIT $ 19 M
  • EBITDA $ 43 M
  • 60-Month Beta 2.03
  • Price/Sales 5.18
  • Price/Cash Flow 28.59
  • Price/Book 1.95

Options Overview Details

View History
  • Implied Volatility 81.03% ( -1.16%)
  • Historical Volatility 65.13%
  • IV Percentile 78%
  • IV Rank 69.69%
  • IV High 109.07% on 04/15/24
  • IV Low 16.55% on 05/29/24
  • Put/Call Vol Ratio 0.43
  • Today's Volume 10
  • Volume Avg (30-Day) 34
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 947
  • Open Int (30-Day) 2,441

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.11
  • Number of Estimates 3
  • High Estimate 0.14
  • Low Estimate 0.08
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +650.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.52 +5.65%
on 03/31/25
Period Open: 34.76
35.20 -14.40%
on 03/03/25
-4.63 (-13.32%)
since 02/28/25
3-Month
28.52 +5.65%
on 03/31/25
Period Open: 40.44
47.32 -36.32%
on 01/30/25
-10.31 (-25.49%)
since 01/02/25
52-Week
18.61 +61.90%
on 04/18/24
Period Open: 20.51
47.32 -36.32%
on 01/30/25
+9.62 (+46.90%)
since 04/02/24

Most Recent Stories

More News
Veracyte: Q4 Earnings Snapshot

Veracyte: Q4 Earnings Snapshot

VCYT : 30.13 (+1.93%)
Brian's Big Idea: Healthcare Stocks

One of the most difficult sectors to invest in is the healthcare sector. Not only do you have to be nuanced in the ways of the stock market but you also have to have a deep understanding of medicines,...

VCYT : 30.13 (+1.93%)
HIMS : 31.22 (+0.55%)
BBIO : 34.62 (+4.85%)
Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Now

Bio-Rad Laboratories, Inc.’s BIO solid momentum in the QX600 Droplet Digital PCR (ddPCR) platform is poised to help it grow in the upcoming quarters. The clinical diagnostics business sees increased...

VCYT : 30.13 (+1.93%)
BIO : 245.52 (+2.30%)
PAHC : 21.90 (-0.32%)
HAE : 64.04 (+1.62%)
Should National Vision Stock Be in Your Portfolio Right Now?

National Vision Holdings, Inc. EYE is winning market shares across four sub segments of the Owned and Host. The company is also advancing its transformation efforts with continued expansion of exam capacity,...

VCYT : 30.13 (+1.93%)
EYE : 12.88 (+0.62%)
PAHC : 21.90 (-0.32%)
HAE : 64.04 (+1.62%)
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down

Neogen's NEOG vast international trade is being impacted by global macroeconomic issues. Also, a tough competitive landscape weighs on the stock. NEOG stock carries a Zacks Rank #4 (Sell) currently.Factors...

VCYT : 30.13 (+1.93%)
PAHC : 21.90 (-0.32%)
NEOG : 8.59 (+2.38%)
HAE : 64.04 (+1.62%)
Henry Schein Stock to Gain From New Acquisitions Amid Macro Woes

Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix.  Yet, global economic uncertainties are concerns for Henry Schein. The stock carries a Zacks Rank...

VCYT : 30.13 (+1.93%)
HSIC : 69.25 (+0.26%)
PAHC : 21.90 (-0.32%)
HAE : 64.04 (+1.62%)
Here's Why You Should Add Ensign Group Stock to Your Portfolio Now

The Ensign Group, Inc. ENSG is benefiting from strategic acquisitions, an expanding footprint, rising service revenues and a strong financial position. An optimistic 2024 business outlook also reinforces...

VCYT : 30.13 (+1.93%)
EMBC : 12.52 (-0.87%)
CDNA : 18.39 (+3.90%)
ENSG : 132.25 (+1.38%)
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave

Through 2024, advancements in AI and predictive analytics rapidly revolutionized the Medical Instruments industry, driving innovation in diagnostics, patient monitoring and personalized treatment. AI-powered...

VCYT : 30.13 (+1.93%)
PEN : 277.35 (+2.29%)
MASI : 171.48 (+2.31%)
Insider Sale: Chief Commercial Officer-CLIA of $VCYT (VCYT) Sells 1,050 Shares

John Leite, the Chief Commercial Officer-CLIA of $VCYT ($VCYT), sold 1,050 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

VCYT : 30.13 (+1.93%)
Insider Sale: VP of $VCYT (VCYT) Sells 5,032 Shares

Jonathan Wygant, the VP of $VCYT ($VCYT), sold 5,032 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 10.6% of their shares....

VCYT : 30.13 (+1.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also...

See More

Key Turning Points

3rd Resistance Point 33.33
2nd Resistance Point 32.10
1st Resistance Point 31.11
Last Price 30.13
1st Support Level 28.90
2nd Support Level 27.67
3rd Support Level 26.68

See More

52-Week High 47.32
Fibonacci 61.8% 36.35
Fibonacci 50% 32.96
Last Price 30.13
Fibonacci 38.2% 29.58
52-Week Low 18.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades